by admin | Dec 13, 2024 | News & Opinions
By Technology Networks – A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia. Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel...
by admin | Dec 12, 2024 | News & Opinions
By Margarida Maia, PhD – Parkinson’s News Today – The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety and an easing in their symptoms over one year of follow-up, the...
by admin | Dec 11, 2024 | News & Opinions
By Nadine A Yehya – UCDavis Health – Funding promotes local production of CAR T-cell immunotherapy for cancer patients UC Davis Health’s Stem Cell Program has received a $500,000 grant from California health insurer Health Net to improve cancer patients’...
by admin | Dec 10, 2024 | News & Opinions
By Caroline Seydel – Genetic Engineering & Biotechnology News – Parkinson’s disease is characterized by the loss of dopamine-producing neurons. The current treatment is oral levodopa, which is taken up by brain neurons and converted to dopamine. But...
by admin | Dec 9, 2024 | News & Opinions
By Stem Cells Translational Medicine – Mesenchymal stem cells (MSCs) hold tremendous potential for regenerative medicine and the treatment of currently incurable diseases. These adult multipotent progenitor cells are essential for tissue regeneration and wound...
by admin | Dec 6, 2024 | News & Opinions
by Lindsey Shapiro, PhD – ALS News Today – Answer ALS and Cedars-Sinai have made openly available their amyotrophic lateral sclerosis (ALS) patient-based stem cell and biodata repository to researchers worldwide. The largest of its kind, the repository...
